Shomron Center for Economic Policy Research

In Search for an efficient Institutions

AI in biology and medicine: perspectives from Jerusalem


A New Paper “Artificial Intelligence in Biology and Medicine, and Radioprotection Research: perspectives from Jerusalem” by Yehoshua Socol, Ariella Richardson, and other colleagues just been published in Frontiers of Artificial Intelligence, Sec. Medicine and Public Health (Volume 6 – 2023).

The paper reviews reports delivered by participants of the workshop on “Artificial Intelligence in Biology and Medicine” (Jerusalem, Feb 14–15, 2023).

Among the reports, the paper’s authors mentioned our (Moshe Yanovskiy and Yair Shaki) presentation:

Moshe Yanovskiy highlighted the ethical challenges of using AI in medical decision-making. While some of these issues, such as the “moral hazard” of asymmetric information (AI developer—AI developer’s expert—medical practitioner—patient), have been discussed for decades, others are more specific to AI (Zheng et al., 2019; Cohen, 2023). Practitioners’ fear of competition or unemployment (a modern form of Luddism), can jeopardize proper deployment of AI systems. However, a more pressing and specific ethical concern is the potential for developers and regulators to promote their subjective choices under the veil of anonymity, thereby imposing them on practitioners and ultimately on patients. This can result in unforeseen and grave consequences (Yanovskiy and Socol, 2023a). For example, including equity as a component of an AI utility function may force AI decisions that might decrease the survival rate of some human cohorts (being unable to increase the survival rate of other cohorts). These and other challenges have led to calls for strict government regulation of AI, but since the government is neither an error-free machine nor a heavenly host (Yanovskiy and Socol, 2023b), caution must be exercised in implementing such standards.”

Leave a Reply

Required fields are marked *.